3VYD
Human renin in complex with inhibitor 6
3VYD の概要
エントリーDOI | 10.2210/pdb3vyd/pdb |
関連するPDBエントリー | 3VYE 3VYF |
分子名称 | Renin, 2-acetamido-2-deoxy-beta-D-glucopyranose, (3S,5R)-5-{[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]methyl}-N-(3-methylbutyl)piperidine-3-carboxamide, ... (4 entities in total) |
機能のキーワード | aspartyl protease, ras, hypertension, inhibitor, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
由来する生物種 | Homo sapiens (human) |
細胞内の位置 | Secreted: P00797 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 75874.49 |
構造登録者 | |
主引用文献 | Mori, Y.,Ogawa, Y.,Mochizuki, A.,Nakamura, Y.,Sugita, C.,Miyazaki, S.,Tamaki, K.,Matsui, Y.,Takahashi, M.,Nagayama, T.,Nagai, Y.,Inoue, S.,Nishi, T. Design and discovery of new (3S,5R)-5-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]piperidine-3-carboxamides as potent renin inhibitors Bioorg.Med.Chem.Lett., 22:7677-7682, 2012 Cited by PubMed Abstract: Utilizing X-ray crystal structure analysis, (3S,5R)-5-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]piperidine-3-carboxamides were designed and identified as renin inhibitors. The most potent compound 15 demonstrated favorable pharmacokinetic and pharmacodynamic profiles in rat. PubMed: 23122821DOI: 10.1016/j.bmcl.2012.09.103 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.81 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
